Videoconference Feasibility Study for MRSA Care Pathways in General Practice, 2020-2022

A feasibility study conducted between October 2020 and December 2022 to develop and test a patient-centered videoconference model for managing low-prevalence diseases like MRSA. The study involved a participatory design workshop with seven end-users and eight real-world videoconference trials, with feedback from eight patients and seven practice staff. The analysis identified themes related to collaboration, shared knowledge, and barriers in using videoconferences for complex care pathways.

Use Cases

• Evaluating the acceptability and feasibility of structured telemedicine consultations based on the described three-phase study design.
• Analyzing barriers and facilitators to implementing videoconferences for complex patient pathways as described in the study's emergent themes.
• Designing patient-centered care protocols for low-prevalence diseases based on the tasks outlined for before, during, and after a videoconference.
• Studying clinician and patient perceptions of telemedicine compared to face-to-face meetings as noted in the findings.

Strengths

• Includes qualitative data from 15 participants (8 patients and 7 practice staff) providing user perspectives.
• Study conducted over a defined period from October 2020 to December 2022, providing temporal context.
• Employs a structured analysis framework (Kvale and Brinkmann’s three interpretative contexts) for the interview data.

Limitations

• Dataset is very small at 34.2 KB, indicating limited scope and likely consisting of a document rather than structured data.
• Row count and column-level documentation are unknown, which limits suitability assessment for quantitative analysis.
• Data reflects a specific case study on MRSA pathways in a Danish-speaking context, which may limit generalizability.

Provenance

Source

Mette Assenholm Kristensen via figshare

Collection Method

Feasibility study using participatory design and qualitative interviews.

Time Range

October 2020 to December 2022

Freshness

Last updated 2026-05-05 07:39:13; freshness should be verified.

Geography

Likely Denmark, based on the mention of Danish-speaking MRSA carriers.